Skip to main content
Have a personal or library account? Click to login
Acute and Subclinical Myocardial Injury in COVID-19 Cover

Acute and Subclinical Myocardial Injury in COVID-19

Open Access
|Dec 2021

Abstract

Coronavirus disease 2019 (COVID-19) is a global pandemic that, at the time of this writing, has led to 178,000,000 cases worldwide and more than 3,875,000 deaths. Cardiovascular complications of COVID-19 have become the focus of investigation after many hospitalized COVID-19 patients—with or without established cardiovascular disease—incurred clinical or subclinical myocardial injury, including isolated biomarker elevations, myocardial infarction, arrhythmia, heart failure, myocarditis, and cardiogenic shock. In this review, we highlight the most recent evidence of the prevalence and potential etiologies of acute and subclinical myocardial injury in COVID-19 patients.

DOI: https://doi.org/10.14797/mdcvj.1038 | Journal eISSN: 1947-6108
Language: English
Page range: 22 - 30
Submitted on: Sep 14, 2021
Accepted on: Oct 11, 2021
Published on: Dec 15, 2021
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2021 Valentina L. Crudo, Ahmed I. Ahmed, Eilidh L. Cowan, Dipan J. Shah, Mouaz H. Al-Mallah, Maan Malahfji, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.